{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T14:16:11Z","timestamp":1785161771954,"version":"3.55.0"},"reference-count":35,"publisher":"Informa UK Limited","issue":"7","license":[{"start":{"date-parts":[[2013,5,21]],"date-time":"2013-05-21T00:00:00Z","timestamp":1369094400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Biological Therapy"],"published-print":{"date-parts":[[2013,8,1]]},"DOI":"10.1517\/14712598.2013.800856","type":"journal-article","created":{"date-parts":[[2013,5,21]],"date-time":"2013-05-21T05:52:09Z","timestamp":1369115529000},"page":"1085-1092","source":"Crossref","is-referenced-by-count":4,"title":["Rozrolimupab, a first-in-class recombinant monoclonal antibody product for primary immune thrombocytopaenia"],"prefix":"10.1517","volume":"13","author":[{"given":"Sandra","family":"Easdale","sequence":"first","affiliation":[{"name":"St George's Hospital, Haematology SpR","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Stasi","sequence":"additional","affiliation":[{"name":"St George's Hospital, Haematology","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2013,5,21]]},"reference":[{"key":"e_1_3_1_3_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH07-08-0513"},{"key":"e_1_3_1_4_1","doi-asserted-by":"publisher","DOI":"10.4065\/79.4.504"},{"key":"e_1_3_1_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.3.909.415k02_909_913"},{"key":"e_1_3_1_6_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04547.x"},{"key":"e_1_3_1_7_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030024"},{"key":"e_1_3_1_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.11.1630"},{"key":"e_1_3_1_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-01-129155"},{"key":"e_1_3_1_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0b013e3282b9748f"},{"key":"e_1_3_1_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-11-4303"},{"key":"e_1_3_1_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-06-438804"},{"key":"e_1_3_1_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0b013e3282b9748f"},{"key":"e_1_3_1_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-0502(03)00043-0"},{"key":"e_1_3_1_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-0502(03)00043-0"},{"key":"e_1_3_1_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V51.5.771.771"},{"key":"e_1_3_1_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V116.21.3687.3687"},{"key":"e_1_3_1_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-005-0445-6"},{"key":"e_1_3_1_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10253"},{"key":"e_1_3_1_20_1","first-page":"72","article-title":"Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases","volume":"90","author":"Vianelli N","year":"2005","unstructured":"Vianelli N, Galli M, de Vivo A, et al. Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases. Haematologica 2005;90:72-7","journal-title":"Haematologica"},{"key":"e_1_3_1_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-04-210112"},{"key":"e_1_3_1_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-12-309153"},{"key":"e_1_3_1_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.04889.x"},{"key":"e_1_3_1_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60203-2"},{"key":"e_1_3_1_25_1","first-page":"98","article-title":"Sustained hemostatic platelet counts in adult patients with primary immune thrombocytopenia (ITP) following cessation of romiplostim: four European case studies (abstract 0237)","volume":"96","author":"Newland A","year":"2010","unstructured":"Newland A, Cervinek L, Eggermann J, et al. Sustained hemostatic platelet counts in adult patients with primary immune thrombocytopenia (ITP) following cessation of romiplostim: four European case studies (abstract 0237). Haemtologica 2010;96:98","journal-title":"Haemtologica"},{"key":"e_1_3_1_26_1","first-page":"734","article-title":"Rozrolimupab, symphobodies against rhesus D, for the potential prevention of hemolytic disease of the newborn and the treatment of idiopathic thrombocytopenic purpura","volume":"12","author":"Stasi R","year":"2010","unstructured":"Stasi R. Rozrolimupab, symphobodies against rhesus D, for the potential prevention of hemolytic disease of the newborn and the treatment of idiopathic thrombocytopenic purpura. Curr Opin Mol Ther 2010;12:734-40","journal-title":"Curr Opin Mol Ther"},{"key":"e_1_3_1_27_1","first-page":"57","article-title":"Anti-RhD immunoglobulin in the treatment of immune thrombocytopenia","volume":"3","author":"Cheung E","year":"2009","unstructured":"Cheung E, Liebman HA. Anti-RhD immunoglobulin in the treatment of immune thrombocytopenia. Biologics 2009;3:57-62","journal-title":"Biologics"},{"key":"e_1_3_1_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V77.9.1884.1884"},{"key":"e_1_3_1_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2008.03735.x"},{"key":"e_1_3_1_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60402-5"},{"key":"e_1_3_1_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-04-1029"},{"key":"e_1_3_1_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.8.2523"},{"key":"e_1_3_1_33_1","first-page":"57","article-title":"Anti-RhD immunoglobulin in the treatment of immune thrombocytopenia","volume":"3","author":"Cheung E","year":"2009","unstructured":"Cheung E, Liebman HA. Anti-RhD immunoglobulin in the treatment of immune thrombocytopenia. Biologics 2009;3:57-62","journal-title":"Biologics"},{"key":"e_1_3_1_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.06985.x"},{"key":"e_1_3_1_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/ilar.46.3.258"},{"key":"e_1_3_1_36_1","doi-asserted-by":"publisher","DOI":"10.1134\/S0006297912080147"},{"key":"e_1_3_1_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.8.2689"}],"container-title":["Expert Opinion on Biological Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14712598.2013.800856","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1517\/14712598.2013.800856","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14712598.2013.800856","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T13:37:44Z","timestamp":1785159464000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14712598.2013.800856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,21]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,8,1]]}},"alternative-id":["10.1517\/14712598.2013.800856"],"URL":"https:\/\/doi.org\/10.1517\/14712598.2013.800856","relation":{},"ISSN":["1471-2598","1744-7682"],"issn-type":[{"value":"1471-2598","type":"print"},{"value":"1744-7682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,21]]}}}